177 related articles for article (PubMed ID: 21420205)
1. Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation.
González-Sánchez I; Solano JD; Loza-Mejía MA; Olvera-Vázquez S; Rodríguez-Sotres R; Morán J; Lira-Rocha A; Cerbón MA
Eur J Med Chem; 2011 Jun; 46(6):2102-8. PubMed ID: 21420205
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling Reveals the Induction of UPR in Addition to DNA Damage Response in HeLa Cells Treated With the Thiazolo[5,4-b]Quinoline Derivative D3ClP.
Páez-Franco JC; González-Sánchez I; Gutiérrez-Nájera NA; Valencia-Turcotte LG; Lira-Rocha A; Cerbón MA; Rodríguez-Sotres R
J Cell Biochem; 2017 May; 118(5):1164-1173. PubMed ID: 27684057
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Voltattorni M; Zini M; Stefanelli C; Masotti L; Shoemaker RH
J Med Chem; 2008 Dec; 51(23):7508-13. PubMed ID: 19006285
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
Alvarez-Ibarra C; Fernández-Granda R; Quiroga ML; Carbonell A; Cárdenas F; Giralt E
J Med Chem; 1997 Feb; 40(5):668-76. PubMed ID: 9057853
[TBL] [Abstract][Full Text] [Related]
7. Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway.
Dinkova-Kostova AT; Cory AH; Bozak RE; Hicks RJ; Cory JG
Cancer Lett; 2007 Jan; 245(1-2):341-9. PubMed ID: 16517063
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs.
Szumilak M; Szulawska-Mroczek A; Koprowska K; Stasiak M; Lewgowd W; Stanczak A; Czyz M
Eur J Med Chem; 2010 Dec; 45(12):5744-51. PubMed ID: 20974504
[TBL] [Abstract][Full Text] [Related]
9. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
10. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
[TBL] [Abstract][Full Text] [Related]
12. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
[TBL] [Abstract][Full Text] [Related]
13. 3-(3-Phenoxybenzyl)amino-β-carboline: a novel antitumor drug targeting α-tubulin.
Ikeda R; Kurosawa M; Okabayashi T; Takei A; Yoshiwara M; Kumakura T; Sakai N; Funatsu O; Morita A; Ikekita M; Nakaike Y; Konakahara T
Bioorg Med Chem Lett; 2011 Aug; 21(16):4784-7. PubMed ID: 21752645
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro.
Minorics R; Szekeres T; Krupitza G; Saiko P; Giessrigl B; Wölfling J; Frank E; Zupkó I
Steroids; 2011 Jan; 76(1-2):156-62. PubMed ID: 20974162
[TBL] [Abstract][Full Text] [Related]
15. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.
Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G
Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells.
Qi YL; Liao F; Zhao CQ; Lin YD; Zuo MX
Acta Pharmacol Sin; 2005 Aug; 26(8):1000-8. PubMed ID: 16038635
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]